Safety and Efficacy of Salvage Lymph Node Dissection in Prostate Cancer Patients With Nodal Recurrence After Radical Prostatectomy With Curative Intent - a Prospective Single Center Phase I/II Study


Condition: Prostate Cancer Recurrent

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT02974075

Sponsor: Medical University of Vienna

Eligibility:

  • Age: minimum 18 Years maximum 75 Years
  • Gender: Male

Inclusion Criteria:

  • Prostate cancer patients with lymph node metastasis in pelvic imaging
  • Status post radical prostatectomy with curative intent
  • Ability for informed consent
  • No sign for bone or visceral metastasis
  • Male > 18 years
  • ECOG performance status 0 or 1

Exclusion Criteria:

  • Male < 18 years
  • No ability for informed consent
  • Sign for bone or visceral metastasis
  • Deep venous thrombosis or pulmonary embolism within the last 6 months before study screening
  • ECOG performance status 2 or more

View trial on ClinicalTrials.gov


email news signup